Form 4: CONMED CFO Sells 3,500 Shares Under 10b5-1 Plan

CONMED Corporation's Executive Vice President and CFO, Todd W. Garner, reported the sale of 3,500 shares of common stock at $43 per share, executed under a pre-arranged 10b5-1 trading plan.

Summary

• Todd W. Garner, Executive Vice President & CFO of CONMED Corp (CNMD), sold 3,500 shares of the company's common stock.
• The transaction occurred on November 6, 2025, at a price of $43 per share.
• The sale was conducted pursuant to a Rule 10b5-1(c) pre-arranged trading plan, which allows insiders to sell shares at a predetermined time or price.
• Following this transaction, Mr. Garner directly beneficially owns 1,836 shares of CONMED common stock.

Sentiment

Score: 4

Explanation: The sale by a key executive, even under a 10b5-1 plan, can be viewed with slight caution as it reduces insider ownership. However, the pre-arranged nature mitigates the negative sentiment compared to an unannounced, opportunistic sale.

Negatives

• A key executive, the CFO, reduced their direct beneficial ownership in the company by selling 3,500 shares, representing a significant portion of their previous holdings.

Stakeholder Impact

• Shareholders may interpret the sale by a key executive as a signal, though the 10b5-1 plan suggests it is not based on new, non-public information. It reduces the CFO's direct financial alignment with common shareholders.

Key Dates

Recommendation

While the sale by the CFO reduces insider ownership, the transaction was executed under a Rule 10b5-1 plan, suggesting it was pre-scheduled and not based on new, material non-public information. This mitigates the negative signal typically associated with insider selling. Investors should monitor future insider activity and company performance rather than reacting solely to this pre-planned sale.

Keywords

CONMED Corp, CNMD, Insider Trading, Form 4, Todd W. Garner, CFO, Stock Sale, 10b5-1 Plan, Executive Compensation